Articles, App Notes, Case Studies, & White Papers
-
How Lipid Nanoparticles Overcome Solubility Challenges
3/7/2023
More than 80% of NCEs are poorly soluble compounds. Overcoming this challenge using lipid nanoparticles is essential to move your drug product through the pipeline and into the market.
-
Combining Gene Therapies, Carrier Systems, And Medical Devices
3/23/2023
Drug delivery is one of the most significant obstacles to advancing gene therapies. Examine the opportunities for success in combining novel medical devices to improve delivery of gene therapies.
-
Outlining The Trends And Challenges In The Inhaled Drug Delivery Market
10/21/2024
Explore the latest trends and solutions in inhaled drug delivery, with a focus on overcoming dry powder formulation challenges to advance next-generation therapeutics.
-
Continuous Manufacturing For API Breakthroughs
7/31/2025
Observe how a compound library, designed for chemical diversity and lead-like properties, uses advanced filtering to improve hit discovery, speed hit-to-lead development, and boost early-stage small molecule drug discovery.
-
The Impact Of PFAS Regulations On Drug Delivery Devices
7/29/2024
By adopting a strategic approach and embracing necessary measures, the medical device industry can transform regulatory challenges surrounding PFAS into opportunities for innovation and growth.
-
Unlocking A Patient Preference For Rapid Onset In Treating Migraines
Examine the case study and learn how formulating an orally disintegrating tablet (ODT) created a convenient dosage form with a shorter Tmax for the treatment of acute migraine.
-
Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives
7/17/2024
A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.
-
Establishing And Safeguarding Shelf Life In Combination Products
10/27/2025
Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.
-
Safeguarding Cell Therapy Cryopreservation: Primary Containers
5/20/2024
Review different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.
-
Overcoming Challenges In Cell And Gene Therapy Containment
Review the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.